About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Gastroenterology and Hepatology
›
top-articles
Department of Gastroenterology and Hepatology
61
(top 2%)
papers
1.8K
(top 1%)
citations
21
(top 1%)
h
-index
43
(top 1%)
g
-index
64
all documents
2.1K
doc citations
702
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Nature
2021
649
2
NAFLD and cardiovascular diseases: a clinical review
Clinical Research in Cardiology
2021
285
3
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
Journal of Hepatology
2022
132
4
Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)
Gut
2013
105
5
Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease
Gastroenterology
2020
103
6
The fecal mycobiome in non-alcoholic fatty liver disease
Journal of Hepatology
2022
66
7
PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO study
European Journal of Cancer
2018
55
8
Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis
Journal of Hepatology
2021
51
9
Impact of Inhibitors of the Renin-Angiotensin-Aldosterone System on Liver Fibrosis and Portal Hypertension
Current Medicinal Chemistry
2006
42
10
New cell surface markers for murine fetal hepatic stem cells identified through high density complementary DNA microarrays
Hepatology
2007
41
11
Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: First results of the CONKO-007 trial.
Journal of Clinical Oncology
2022
39
12
Botox, dilation, or myotomy? Clinical outcome of interventional and surgical therapies for achalasia
Langenbeck's Archives of Surgery
2010
38
13
CONKO-005: Adjuvant therapy in R0 resected pancreatic cancer patients with gemcitabine plus erlotinib versus gemcitabine for 24 weeks—A prospective randomized phase III study.
Journal of Clinical Oncology
2015
35
14
Yersinia pseudotuberculosis bloodstream infection and septic arthritis: case report and review of the literature
Infection
2012
34
15
Cytolysin‐positive
Enterococcus faecalis
is not increased in patients with non‐alcoholic steatohepatitis
Liver International
2020
29
16
Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’
Anti-Cancer Drugs
2010
28
17
High Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD
Hepatology Communications
2020
28
18
Hepatosplenic candidiasis
Clinical Liver Disease
2015
27
19
Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
Journal of Gastroenterology and Hepatology (Australia)
2020
27
20
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
Liver Cancer
2021
25
21
Acoustic Structure Quantification Ultrasound Software Proves Imprecise in Assessing Liver Fibrosis or Cirrhosis in Parenchymal Liver Diseases
Ultrasound in Medicine and Biology
2014
23
22
Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the ‘burden of therapy’ method
European Journal of Cancer
2021
21
23
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools
Scientific Reports
2020
20
24
Maternal exercise conveys protection against NAFLD in the offspring via hepatic metabolic programming
Scientific Reports
2020
18
25
Neighbor of punc E11, a novel oncofetal marker for hepatocellular carcinoma
International Journal of Cancer
2011
15
26
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results
European Journal of Cancer
2020
15
27
Structured Reporting of Solid and Cystic Pancreatic Lesions in CT and MRI: Consensus-Based Structured Report Templates of the German Society of Radiology (DRG)
RoFo Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren
2020
15
28
Neighbor of Punc E 11: Expression Pattern of the New Hepatic Stem/Progenitor Cell Marker During Murine Liver Development
Stem Cells and Development
2012
14
29
Hepatocyte expression of angiotensin II type 1 receptor is downregulated in advanced human liver fibrosis
Liver International
2009
11
30
Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo
Journal of Hepatology
2011
11
31
Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target
Molecular and Clinical Oncology
2017
11
32
Combined analysis of gut microbiota, diet and
PNPLA3
polymorphism in biopsy‐proven non‐alcoholic fatty liver disease
Liver International
2021
11
33
Fatal disseminated enterovirus infection in a patient with follicular lymphoma undergoing obinutuzumab maintenance therapy
European Journal of Haematology
2019
8
34
Panitumumab in combination with gemcitabine/cisplatin (GemCis) for patients with advanced kRAS WT biliary tract cancer: A randomized phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Journal of Clinical Oncology
2015
8
35
Perioperative or adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Updated final results of the randomized phase II AIO-NEONAX trial.
Journal of Clinical Oncology
2022
8
36
HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?
Infection
2019
6
37
Hepatocellular carcinoma surveillance with liver imaging is not associated with improved survival
Scandinavian Journal of Gastroenterology
2020
6
38
Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome
Hepatology
2023
6
39
Randomized dose comparison phase II study of the oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor LY2157299 monohydrate (LY) in patients with advanced hepatocellular carcinoma (HCC).
Journal of Clinical Oncology
2013
5
40
Contrast-Enhanced Ultrasound for the Detection of Abdominal Complications in Infective Endocarditis: First Experience From a Prospective Cohort
Ultrasound in Medicine and Biology
2020
4
41
Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study
BMC Cancer
2020
3
42
First evaluation of Neighbor of Punc E11 (NOPE) as a novel marker in human hepatocellular carcinoma
Cancer Biomarkers
2021
3
43
C-MET mRNA expression in pancreatic ductal adenocarcinoma and stromal tissue: Prognostic and therapeutic implications.
Journal of Clinical Oncology
2014
3
44
ACCEPT: Afatinib as cancer therapy for exocrine pancreatic tumors–An explorative randomized phase II trial.
Journal of Clinical Oncology
2015
2
45
Dietary omega-6/omega-3 ratio is not associated with gut microbiota composition and disease severity in patients with nonalcoholic fatty liver disease
Nutrition Research
2022
2
46
A peculiar case of autoimmune pancreatitis and sclerosing cholangitis
Endoscopy
2012
1
47
Gemcitabine plus afatinib versus gemcitabine alone in metastatic pancreatic cancer: An explorative randomized AIO phase II trial (ACCEPT)
Annals of Oncology
2018
1
48
Successful use of TNFα blockade in a severe case of idiopathic non-granulomatous ulcerative jejunoileitis associated with thrombotic thrombocytopenic purpura
BMJ Open Gastroenterology
2019
1
49
Palliation of malignant dysphagia with a segmented self-expanding metal stent
Medicine (United States)
2021
1
50
Correlation of hand-foot skin reaction (HFS) with treatment efficacy in pancreatic cancer (PC) patients (pts) treated with gemcitabine/capecitabine plus erlotinib: A subgroup analysis from the AIO-PK0104 randomized, cross-over phase III trial in advanced PC.
Journal of Clinical Oncology
2012
1
site/software ©
exaly
; All materials licenced under
CC by-SA
.